Likewise, significant low expression of SST and CORT neuropeptides was also observed in GBM vs. control samples (Fig. 1E), with AUC > 0.9, indicating also a high discriminatory capacity of these ligands (Fig. 1F). This evidence concerns the gene SST and glioblastoma.